Cardiology
- Should we monitor troponin up to peak value when evaluating for acute coronary syndrome?
No. Once troponin is over the 99th percentile, finding the peak value does not aid in diagnosis.
- Cardiac troponin testing: Goodbye, ‘troponinemia’
Any troponin elevation is prognostically important; dismissing it as “troponinemia” is no longer a viable strategy.
- Does a short QT interval increase the risk of cardiac death in healthy people?
No, but it may warrant further investigation to determine if the patient is at risk.
- The role of ISCHEMIA in stable ischemic heart disease
Decisions regarding treatment of stable ischemic heart disease must remain individualized.
- Stable coronary artery disease: Intervene or not?
Stable coronary artery disease needs a patient-centered approach, and one size does not fit all.
- Procedures and devices to treat resistant hypertension in chronic kidney disease
These treatments show potential. All but renal artery stenting are still experimental.
- Device-based therapies for resistant hypertension in chronic kidney disease: The continuing quest for a cure
Device-based therapies have shown promise, but many points still need clarification.
- Medical complications of anorexia nervosa
Many of these complications resolve with treatment and weight gain, but others can lead to permanent damage.